Skip to main content
. Author manuscript; available in PMC: 2021 Feb 14.
Published in final edited form as: Methods Mol Biol. 2016;1436:147–165. doi: 10.1007/978-1-4939-3667-0_11

Table 1.

Subpopulation Surface markers
Test A: Common myeloid progenitors (CMP) CD3−,CD19−,NK1.1−,CD11B−,Ly6G−,CD45+, CD117High, CD127−
Test A: Myeloblasts CD45int, SSClow, CD117+,Ly6G−
Test A: Promyelocytes CD45int, SSChigh, CD117+, Ly6G−
Test B: Triple-negative DCs CD3−, CD19−,NK1.1−, CD11C+, CD11B−, CD8−, CD4−
Test B: Double-negative DCs CD3−, CD19−, NK1.1−, CD11C+, CD11B+, CD8−, CD4−
Test B: CD4+ DCs CD3−, CD19−, NK1.1−, CD11C+, CD11B+, CD8−, CD4+
Test B: CD8+ DCs CD3−, CD19−, NK1.1−, CD11C+, CD11B+, CD8+, CD4−
Test C: Classical monocytes CD3−, Nk1.1−, CD115+, CD45R−, MHCII−, Ly6C−, CD43−
Test C: Nonclassical monocytes CD3−, Nk1.1−, CD115+, CD45R, MHCII−, Ly6C+, CD43+
Test D: Neutrophils CD3−,CD19−,NK1.1−,CD11C−,CD11B+, Ly6G+
Test D: Eosinophils CD3−,CD19−,NK1.1,CD11C−,CD11B+,Ly6G−,SSChigh,Ly6Clow/−